✦ LIBER ✦

Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma

✍ Scribed by Iuchi, T.; Shingyoji, M.; Sakaida, T.; Hatano, K.; Nagano, O.; Itakura, M.; Kageyama, H.; Yokoi, S.; Hasegawa, Y.; Kawasaki, K.; Iizasa, T.

Book ID: 121183055
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 973 KB
Volume: 82
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2013.08.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acquired Resistance to EGFR Tyrosine Kin

Acquired Resistance to EGFR Tyrosine Kinase Inhibitors is Associated With Low Efficacy of Radiation Therapy for Brain Metastases From EGFR-mutant Lung Adenocarcinoma

✍ Hirata, H.; Nakamura, K.; Kunitake, N.; Shioyama, Y.; Sasaki, T.; Nonoshita, T.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Phase II Study of WBRT With or Without C

Phase II Study of WBRT With or Without Concurrent Erlotinib for Patients With Brain Metastases From Lung Adenocarcinoma

✍ Zhuang, H.; Yuan, Z.; Wang, J.; Zhao, L.; Wang, P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Phase 1 Trial of Icotinib Combined With

Phase 1 Trial of Icotinib Combined With Whole-Brain Radiation Therapy for EGFR-Mutated Non-Small Cell Lung Cancer Patients With Brain Metastases: Updated Results

✍ Zhou, L.; He, J.; Xiong, W.; Yu, Q.; Xiang, J.; Liang, M.; Xue, J.; Liu, Y.; Din 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Phase II Study of Erlotinib with Concurr

Phase II Study of Erlotinib with Concurrent Whole-brain Radiation Therapy for Patients with Brain Metastases from Non-small Cell Lung Cancer

✍ J.W. Welsh; E. Kim; A. Amini; P. Allen; J. Chang; R. Komaki; N. Nguyen; J. Holt; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

505 POSTER Preliminary results of a phas

505 POSTER Preliminary results of a phase II clinical trial of the anti EGFR monoclonal antibody Nimotuzumab in combination with whole brain radiation therapy in patients diagnosed with advanced non-small cell lung cancer tumors unresectable brain metastases

✍ A. Macias; E. Neninger; E. Santiesteban; J. Figueredo; A. Hernandez; F. Aguirre; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Outcome, quality of life and cognitive f

Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)

✍ Gianfranco A. Pesce; Dirk Klingbiel; Karin Ribi; Abderahim Zouhair; Roger von Mo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 433 KB